Merck KGaA (MKKGY) Expected to Post Quarterly Earnings on Thursday

Merck KGaA (OTCMKTS:MKKGY) will likely be posting its results before the market opens on Thursday, August 6th. Analysts expect the company to post earnings of $0.47 per share and revenue of $6.0806 billion for the quarter.

Merck KGaA (OTCMKTS:MKKGY) last announced its earnings results on Wednesday, May 13th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.14. The business had revenue of $6.03 billion during the quarter, compared to analyst estimates of $5.93 billion. Merck KGaA had a return on equity of 8.79% and a net margin of 12.07%. On average, analysts expect Merck KGaA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Merck KGaA Stock Down 0.8%

Shares of MKKGY opened at $32.91 on Tuesday. The stock’s 50-day moving average price is $31.78 and its two-hundred day moving average price is $29.11. Merck KGaA has a 12 month low of $23.73 and a 12 month high of $34.19. The company has a market capitalization of $21.27 billion, a PE ratio of 14.63, a PEG ratio of 2.92 and a beta of 0.98. The company has a current ratio of 1.51, a quick ratio of 1.00 and a debt-to-equity ratio of 0.36.

Wall Street Analysts Forecast Growth

MKKGY has been the subject of several recent research reports. Jefferies Financial Group began coverage on Merck KGaA in a research note on Tuesday, May 26th. They issued a “hold” rating for the company. HSBC raised Merck KGaA to a “hold” rating in a research note on Monday, July 6th. Finally, Zacks Research raised shares of Merck KGaA from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold”.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.